Eptifibatide Acetate

Eptifibatide, is an antiplatelet drug of the glycoprotein IIb/IIIa inhibitor class. Eptifibatide is a cyclic heptapeptide derived from a protein found in the venom of the southeastern pygmy rattlesnake (Sistrurus miliarius barbouri). It belongs to the class of the so-called RGD (arginine-glycine-aspartate)-mimetics and reversibly binds to platelets.

Online Inquiry

CAT#10-101-15
CAS188627-80-7 (net)
Synonyms/AliasEptifibatide; Integrilin; CHEBI:291902
Chemical Name2-[20-carbamoyl-12-[4-(diaminomethylideneamino)butyl]-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,22-hexaoxo-17,18-dithia-1,4,7,10,13,21-hexazabicyclo[21.3.0]hexacosan-6-yl]acetic acid
M.F/FormulaC35H49N11O9S2
M.W/Mr.832.4
Sequence[Mpa1-Cys6] Mpa-Har-Gly-Asp-Trp-Pro-Cys-NH2
Labeling TargetIntegrin
ApplicationEptifibatide is used to treat myocardial infarction and acute coronary syndrome.
AppearanceSolid powder
Purity>98% (or refer to the Certificate of Analysis)
ActivityInhibitor
Areas of InterestCardiovascular System & Diseases
Pituitary & Hypothalamic Hormones
FunctionsVirus receptor activity
DiseaseAcute coronary syndrome;
Percutaneous coronary intervention
TargetIntegrin
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Customer Support & Price Inquiry

* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).

Contact Us

Address:

Tel: |

Email:

Copyright © 2022 Creative Peptides. All rights reserved.